MCLVX
Price
$26.03
Change
-$0.69 (-2.58%)
Updated
Dec 18 closing price
RMFCX
Price
$54.22
Change
-$1.42 (-2.55%)
Updated
Dec 18 closing price
Ad is loading...

MCLVX vs RMFCX

Header iconMCLVX vs RMFCX Comparison
Open Charts MCLVX vs RMFCXBanner chart's image
BlackRock Advantage Large Cap Val Inv C
Price$26.03
Change-$0.69 (-2.58%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.22
Change-$1.42 (-2.55%)
VolumeN/A
CapitalizationN/A
MCLVX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MCLVX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MCLVX is a Hold and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 98.7B vs. MCLVX (650M). RMFCX pays higher dividends than MCLVX: RMFCX (1.69) vs MCLVX (0.80). MCLVX was incepted earlier than RMFCX: MCLVX (25 years) vs RMFCX (23 years). MCLVX is a more actively managed with annual turnover of: 116.00 vs. RMFCX (25.00). RMFCX has a lower initial minimum investment than MCLVX: RMFCX (250) vs MCLVX (1000). RMFCX annual gain was more profitable for investors over the last year : 12.63 vs. MCLVX (3.15). RMFCX return over 5 years is better than : 40.39 vs. MCLVX (6.50).
MCLVXRMFCXMCLVX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence25 years23 years-
Gain YTD2.08911.42318%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets650M98.7B1%
Annual Yield % from dividends0.801.6947%
Returns for 1 year3.1512.6325%
Returns for 3 years0.7014.165%
Returns for 5 years6.5040.3916%
Returns for 10 years33.6161.8454%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc